Literature DB >> 11929141

Influence of dialysate on gastric emptying time in peritoneal dialysis patients.

VlemBrunoA Van1, Renaat S Schoonjans, Dirk G Struijk, Johan J Verbanck, Raymond C Vanholder, BiesenWimV Van, Romain A Lefebvre, VosMartineP De, Norbert H Lameire.   

Abstract

OBJECTIVE: Peritoneal dialysis (PD) patients frequently suffer from dyspeptic complaints such as nausea, vomiting, abdominal distension, early satiety, and anorexia. Gastroparesis might be, at least partially, a source of dyspeptic complaints in PD patients. The aim of the present study was to determine the influence of the presence and composition of dialysate on gastric emptying in PD patients.
DESIGN: Prospective study.
SETTING: Renal Division, Department of Internal Medicine, Ghent University Hospital, Belgium. PATIENTS: Sixty-one PD patients using different dialysate solutions, and 27 healthy volunteers. MAIN OUTCOME MEASURE: Gastric emptying of solids was assessed by the 13C-octanoic acid breath test.
RESULTS: Gastric emptying was impaired in PD patients, regardless of the composition of dialysate and even if tested with an empty peritoneal cavity. Gastric emptying was significantly slower when glucose-containing dialysate was compared to an empty peritoneal cavity, or when glucose-containing dialysate was compared to icodextrin dialysate. No difference in gastric emptying could be demonstrated between glucose-containing dialysate and dialysate containing a mixture of glycerol and amino acids as osmotic agent.
CONCLUSIONS: These findings suggest that the delay in gastric emptying demonstrated in the presence of peritoneal dialysate is not the consequence of a mere volume or pressure effect, but of the absorption of substrate substances with caloric and/or metabolic activity, such as glucose or glycerol and amino acids.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929141

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  13 in total

1.  Gastrointestinal symptoms in patients undergoing peritoneal dialysis: multivariate analysis of correlated factors.

Authors:  Rui Dong; Zhi-Yong Guo
Journal:  World J Gastroenterol       Date:  2010-06-14       Impact factor: 5.742

Review 2.  Nutrition in patients on peritoneal dialysis.

Authors:  Seung-Hyeok Han; Dae-Suk Han
Journal:  Nat Rev Nephrol       Date:  2012-02-07       Impact factor: 28.314

3.  Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.

Authors:  Yuji Takatori; Shigeru Akagi; Hitoshi Sugiyama; Junko Inoue; Shoichiro Kojo; Hiroshi Morinaga; Kazushi Nakao; Jun Wada; Hirofumi Makino
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 8.237

Review 4.  Diets and enteral supplements for improving outcomes in chronic kidney disease.

Authors:  Kamyar Kalantar-Zadeh; Noël J Cano; Klemens Budde; Charles Chazot; Csaba P Kovesdy; Robert H Mak; Rajnish Mehrotra; Dominic S Raj; Ashwini R Sehgal; Peter Stenvinkel; T Alp Ikizler
Journal:  Nat Rev Nephrol       Date:  2011-05-31       Impact factor: 28.314

5.  Icodextrin produces higher ultrafiltration in diabetic than in non-diabetic patients on continuous cyclic peritoneal dialysis.

Authors:  Mufazzal Ahmad; Tarun Jeloka; Theodoros Pliakogiannis; Shruti Tapiawala; Hui Zhong; Joanne M Bargman; Dimitrios Oreopoulos
Journal:  Int Urol Nephrol       Date:  2007-11-08       Impact factor: 2.370

6.  Gastrointestinal symptoms: a comparison between patients undergoing peritoneal dialysis and hemodialysis.

Authors:  Rui Dong; Zhi-Yong Guo; Jia-Rong Ding; Yang-Yang Zhou; Hao Wu
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 7.  The Gut in Older Patients on Peritoneal Dialysis.

Authors:  Stella Setyapranata; Stephen G Holt
Journal:  Perit Dial Int       Date:  2015-11       Impact factor: 1.756

8.  Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients.

Authors:  Alastair J Hutchison; Maggie Gill; J Brian Copley; Lynne Poole; Rosamund J Wilson
Journal:  BMC Nephrol       Date:  2013-02-18       Impact factor: 2.388

9.  Icodextrin improves the serum potassium profile with the enhancement of nutritional status in continuous ambulatory peritoneal dialysis patients.

Authors:  Joo-Hark Yi; Jae-Il Park; Hoon-Young Choi; Ho-Yung Lee; Sang-Woong Han; Ho-Jung Kim
Journal:  Electrolyte Blood Press       Date:  2009-12-31

10.  Future technologies and techniques in peritoneal dialysis-opportunities and challenges ahead.

Authors:  Clifford J Holmes; Watske Smit
Journal:  NDT Plus       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.